The Impact of Stationary Combined Exercise on Adiponectin and Hs-CRP Levels in Overweight Women (SCEX-ADCRP)

November 15, 2025 updated by: Xianjie Zheng

The Impact of Stationary Combined Exercise on Adiponectin and High-Sensitivity C-Reactive Protein Levels in Overweight Women

This study looked at whether a specific exercise program can improve inflammatory markers in overweight young women. We tested an eight-week, circuit-style exercise program that combines aerobic and resistance activities (e.g., sit-ups, step jumps, push-ups, jump rope, jumping jacks, medicine-ball lifts). Participants exercised four times per week at a moderate-to-high intensity, with a warm-up and cool-down at each session.

Twenty-two women (ages 20-30 years; BMI 25-31 kg/m²) were randomly assigned to one of two groups: (1) the exercise group completed the training program; (2) the control group continued usual daily activities without a structured program. Before starting and 48 hours after finishing the program, we took fasting blood samples to measure two markers: adiponectin (a hormone made by fat tissue that supports healthy metabolism and has anti-inflammatory effects) and high-sensitivity C-reactive protein (hs-CRP) (a blood marker of inflammation and cardiovascular risk).

The main outcomes were the changes in adiponectin and hs-CRP from before to after the 8-week period. We also recorded weight, body mass index (BMI), body fat percentage, and fitness (VO₂max). The study was conducted at the Exercise Physiology Laboratory, College of Physical Education and Health, Chongqing College of International Business and Economics (Chongqing, China). The research ethics committee approved the protocol, and all participants provided written informed consent.

Recruitment and data collection are complete. Findings suggest that this circuit-based exercise program can increase adiponectin and lower hs-CRP, alongside improvements in body composition, in overweight young women.

Study Overview

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chongqing, China
        • College of Physical Education and Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Female sex Age 20 to 30 years BMI 25 to 31 kg/m² Body weight 63 to 87 kg Generally healthy, without diagnosed chronic illness Willing and able to provide written informed consent Willing to refrain from vigorous physical activity for 48 hours before blood sampling Able to attend 4 supervised training sessions per week for 8 weeks (if assigned to intervention)

Exclusion Criteria:

History of cardiovascular disease, hypertension, or diabetes Current smoking or tobacco use Current use of medications or supplements that affect metabolism or inflammatory markers Pregnancy or breastfeeding Contraindications to moderate-to-high intensity exercise on screening Participation in regular vigorous exercise training within the past 6 months Inability or unwillingness to comply with study procedures (e.g., missing >2 consecutive training sessions)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Combined Exercise Group
Arm 1 reflects the circuit-based combined exercise intervention.
Participants completed an eight-week circuit-based combined exercise program, four sessions per week, at an intensity of 70-90% of maximum heart rate. Each session began with a 10-15 minute warm-up (stretching and light jogging) and ended with a 5-10 minute cool-down (walking and stretching). The main exercise protocol included six stations (sit-ups, step jumps, push-ups, jump rope, jumping jacks, and medicine ball lifting), performed in three rounds. The duration at each station progressively increased from 60 seconds (weeks 1-2) to 150 seconds (weeks 7-8), with rest intervals of 30-50 seconds between stations and 3-5 minutes between rounds. Exercise intensity was monitored with a Polar heart rate monitor to ensure participants stayed within the target zone.
Other Names:
  • High-Intensity Circuit-Based Combined Exercise
  • Combined Stationary Exercise
  • SCEX Program (Stationary Combined Exercise)
Experimental: Control Group
Arm 2 reflects the no structured exercise condition.
Participants in the control group will not receive any structured exercise program during the eight-week study period. They will be instructed to maintain their usual daily routines and refrain from initiating any new organized exercise or training programs beyond their routine physical education classes and everyday activities.
Other Names:
  • Usual Activity
  • No Exercise Program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Serum Adiponectin Concentration
Time Frame: Baseline and 48 hours post-intervention (end of week 8).
Serum adiponectin (µg/mL) quantified by ELISA in the fasting state; difference from baseline to 48 hours after completion of the 8-week exercise program.
Baseline and 48 hours post-intervention (end of week 8).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Serum Adiponectin Concentration
Time Frame: Baseline and 48 hours post-intervention (end of week 8).
Serum adiponectin (µg/mL) quantified by ELISA in the fasting state; difference from baseline to 48 hours after completion of the 8-week exercise program.
Baseline and 48 hours post-intervention (end of week 8).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2024

Primary Completion (Actual)

April 10, 2024

Study Completion (Actual)

April 10, 2024

Study Registration Dates

First Submitted

September 13, 2025

First Submitted That Met QC Criteria

November 14, 2025

First Posted (Estimated)

November 17, 2025

Study Record Updates

Last Update Posted (Actual)

November 19, 2025

Last Update Submitted That Met QC Criteria

November 15, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • College of Physical Education
  • K2016038 (Registry Identifier: Ethics Approval Number (Chongqing College of International Business and Economics Research Ethics Committee).)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Combined Exercise Group

Subscribe